The estimated Net Worth of David G Foster is at least $1.53 Milion dollars as of 31 December 2020. David Foster owns over 27,240 units of Immunogen stock worth over $1,529,635 and over the last 6 years David sold IMGN stock worth over $0.
David has made over 2 trades of the Immunogen stock since 2020, according to the Form 4 filled with the SEC. Most recently David exercised 27,240 units of IMGN stock worth $850,978 on 31 December 2020.
The largest trade David's ever made was exercising 27,240 units of Immunogen stock on 31 December 2020 worth over $850,978. On average, David trades about 4,127 units every 25 days since 2019. As of 31 December 2020 David still owns at least 48,964 units of Immunogen stock.
You can see the complete history of David Foster stock trades at the bottom of the page.
David's mailing address filed with the SEC is 22 Hillside Dr, Townsend, MA 01469, USA.
Over the last 21 years, insiders at Immunogen have traded over $72,947,831 worth of Immunogen stock and bought 303,125 units worth $974,603 . The most active insiders traders include Biochem Incshire Pharmaceut..., Capital, L.P.Morton Holding... oraz Mark J Enyedy. On average, Immunogen executives and independent directors trade stock every 34 days with the average trade being worth of $2,554,057. The most recent stock trade was executed by Stacy Ann Coen on 2 February 2024, trading 14,350 units of IMGN stock currently worth $448,294.
immunogen is a clinical-stage biotechnology company that develops targeted anticancer therapeutics with its proprietary antibody-drug conjugate (adc) technology. the company's lead product candidate, mirvetuximab soravtansine, is a potential treatment for folate receptor α-positive ovarian cancers and other solid tumors. leading healthcare companies have licensed rights to use immunogen's technology to develop novel anticancer therapies, and roche's marketed product, kadcyla, utilizes immunogen's adc technology. more information about the company can be found at www.immunogen.com.
Immunogen executives and other stock owners filed with the SEC include: